AlleSense has developed a unique and novel solution to label-free imaging, the NanoMslide – the world-first nanofabricated microscope slide.

The NanoMslide uses colour contrast to easily and quickly identify abnormal cells in a suspect sample. It works by applying a special coating created using cutting edge nanofabrication technology, to the humble glass microscope slide, effectively turning it into a miniature chemistry lab, reducing time and removing dyes from the process. 

By manipulating the interaction of light with tissues at the nanoscale it removes the need for any chemicals, specialised equipment or training. It can be applied to any tissue and has shown significant promise in aiding the diagnosis of early stage and difficult-to-diagnose cancers, including breast cancer.

The launch of AlleSense follows eight years of intensive research by a team at Australia’s La Trobe University, in collaboration with the Peter MacCallum Cancer Centre and Garvan Institute of Medical Research. The technology will undergo rapid clinical translation and be available for research use by the end of 2024.